Next Generation Immunotherapies Market Report 2026
Download Free Sample Buy Now
Next Generation Immunotherapies Market Global Report 2026 Market Report Infographic Image

Published : April 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Next Generation Immunotherapies Market Report 2026

Global Outlook – By Drug Class (Monoclonal Antibodies, Antibody-Drug Conjugates (ADCs), Angiotensin-Converting Enzyme (ACE) Inhibitors, Immune Checkpoint Inhibitors), By Route Of Administration (Intravenous, Parenteral, Intratumoral, Subcutaneous, Oral), By Distribution Channel (Hospital Pharmacies, Clinical Pharmacies, Other Distribution Channels) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Next Generation Immunotherapies Market Overview

• Next Generation Immunotherapies market size has reached to $150.12 billion in 2025

• Expected to grow to $262.82 billion in 2030 at a compound annual growth rate (CAGR) of 11.8%

• Growth Driver: Rising Cancer Prevalence Driving Growth In The Market

• Market Trend: Innovative CAR T-Cell Therapy Revolutionizes Cancer Treatment In India

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Next Generation Immunotherapies Market?

Next-generation immunotherapies refer to advanced treatments designed to enhance the body's immune system to fight diseases, particularly cancer, with improved precision, efficacy, and safety. These therapies go beyond traditional immune-based treatments by leveraging cutting-edge technologies and aim to overcome earlier immunotherapies' limitations, reduce side effects, and offer long-lasting immune responses.

The main drug classes in the next-generation immunotherapies are monoclonal antibodies, antibody-drug conjugates (ADCs), angiotensin-converting enzyme (ACE) inhibitors, and immune checkpoint inhibitors. Monoclonal antibodies are lab-engineered proteins designed to precisely target specific antigens, enhancing immune response and treatment effectiveness. These drugs are administered through various routes, including intravenous, parenteral, intratumoral, subcutaneous, and oral. They are distributed through multiple channels, such as hospital pharmacies, clinical pharmacies, and other distribution channels.

Next Generation Immunotherapies Market Global Report 2026 Market Report bar graph

What Is The Next Generation Immunotherapies Market Size and Share 2026?

The next generation immunotherapies market size has grown rapidly in recent years. It will grow from $150.12 billion in 2025 to $168.33 billion in 2026 at a compound annual growth rate (CAGR) of 12.1%. The growth in the historic period can be attributed to rising global cancer prevalence, early success of immune checkpoint inhibitors, increased oncology r&d investments, regulatory approvals of monoclonal antibodies, growing awareness of immuno-oncology therapies.

What Is The Next Generation Immunotherapies Market Growth Forecast?

The next generation immunotherapies market size is expected to see rapid growth in the next few years. It will grow to $262.82 billion in 2030 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to advancements in next-generation antibody engineering, expanding applications beyond oncology, increasing approval of adc-based therapies, growth in biomarker-driven treatment selection, rising demand for durable and long-lasting therapies. Major trends in the forecast period include expansion of combination immunotherapy regimens, growth in personalized cancer vaccines, rising adoption of bispecific antibodies, increasing focus on reducing immune-related adverse events, accelerated clinical trial activity in solid tumors.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Next Generation Immunotherapies Market Segmentation

1) By Drug Class: Monoclonal Antibodies, Antibody-Drug Conjugates (ADCs), Angiotensin-Converting Enzyme (ACE) Inhibitors, Immune Checkpoint Inhibitors

2) By Route Of Administration: Intravenous, Parenteral, Intratumoral, Subcutaneous, Oral

3) By Distribution Channel: Hospital Pharmacies, Clinical Pharmacies, Other Distribution Channels

Subsegments:

1) By Monoclonal Antibodies: Anti-PD-1 Antibodies, Anti-PD-L1 Antibodies, Anti-CTLA-4 Antibodies, Anti-CD20 Antibodies

2) By Antibody-Drug Conjugates (ADCs): HER2-Targeted ADCs, CD30-Targeted ADCs, CD19-Targeted ADCs

3) By Angiotensin-Converting Enzyme (ACE) Inhibitors: ACE Inhibitors For Cancer Therapy, ACE Inhibitors For Other Indications

4) By Immune Checkpoint Inhibitors: PD-1 Or PD-L1 Inhibitors, CTLA-4 Inhibitors

What Is The Driver Of The Next Generation Immunotherapies Market?

The increasing prevalence of cancer is expected to propel the growth of the next-generation immunotherapies market going forward. Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body. The prevalence of cancer is due to factors such as aging populations, lifestyle changes, environmental exposures, and improved detection methods. Next-generation immunotherapies provide advanced, targeted treatments that enhance the body's immune response to cancer, offering greater effectiveness, durability, and personalization. For instance, in July 2024, according to the projections published by Cancer Research UK, a UK-based cancer charity, cancer incidence rates in the United Kingdom are projected to increase for most types between 2023-2025 and 2038-2040, with rises ranging from less than 1% for breast cancer to 50% for eye cancer, while a smaller number of cancers are expected to see a decline, with reductions ranging from 2% for lung cancer to 27% for mesothelioma. Therefore, the increasing prevalence of cancer is driving the growth of next-generation immunotherapies market.

Key Players In The Global Next Generation Immunotherapies Market

Major companies operating in the next generation immunotherapies market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc (GSK), Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Boehringer Ingelheim International GmbH, Regeneron Pharmaceuticals Inc., Incyte Corporation, BioNTech SE, Xencor Inc., Fate Therapeutics Inc., Immatics N.V., Atara Biotherapeutics Inc., Menarini Group, Alpine Immune Sciences Inc., Mereo Biopharma Group plc, Immunomic Therapeutics Inc., Indaptus Therapeutics Inc.

Global Next Generation Immunotherapies Market Trends and Insights

Major companies operating in the next-generation immunotherapies market are focusing on developing innovative therapies, such as CAR T-cell therapy, to treat cancers, autoimmune diseases, and infectious diseases. CAR T-cell therapy is a type of immunotherapy where a patient's T cells (a type of immune cell) are genetically engineered to express chimeric antigen receptors (CARs). For instance, in January 2025, Immuneel Therapeutics Private Limited, an India-based cell and gene therapy startup, launched Qartemi, an India's first CAR T-cell therapy. This therapy is for adult B-cell non-Hodgkin lymphoma, genetically modifying a patient's immune cells to target and destroy cancer cells, offering a highly effective and personalized treatment option. It provides renewed hope to patients for whom conventional treatments have proven ineffective, with the advantage of being more affordable than similar global options.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Next Generation Immunotherapies Market?

In September 2023, Coherus BioSciences Inc., a US-based biopharmaceutical company, acquired Surface Oncology Inc. for an undisclosed amount. With this acquisition, Coherus BioSciences aims to expand its immuno-oncology portfolio by introducing novel therapies that target the tumor microenvironment to enhance cancer treatment. Surface Oncology Inc. is a US-based immuno-oncology (I-O) company that focuses on developing next-generation immunotherapies designed to target the tumor microenvironment.

Regional Outlook

North America was the largest region in the next-generation immunotherapies market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Next Generation Immunotherapies Market?

The next-generation immunotherapies market consists of revenues earned by entities providing services such as cell therapy manufacturing services, gene editing and engineering services, consulting services, diagnostic services, and distribution and logistics. The market value includes the value of related goods sold by the service provider or included within the service offering. The next-generation immunotherapies market also includes sales of CAR-T cell therapies, natural killer (NK) cell therapies, combination therapies, and checkpoint inhibitors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Next Generation Immunotherapies Market Report 2026?

The next generation immunotherapies market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the next generation immunotherapies industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Next Generation Immunotherapies Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $168.33 billion
Revenue Forecast In 2035 $262.82 billion
Growth Rate CAGR of 12.1% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Drug Class, Route Of Administration, Distribution Channel
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc (GSK), Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Boehringer Ingelheim International GmbH, Regeneron Pharmaceuticals Inc., Incyte Corporation, BioNTech SE, Xencor Inc., Fate Therapeutics Inc., Immatics N.V., Atara Biotherapeutics Inc., Menarini Group, Alpine Immune Sciences Inc., Mereo Biopharma Group plc, Immunomic Therapeutics Inc., Indaptus Therapeutics Inc.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Next Generation Immunotherapies Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Next Generation Immunotherapies Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Next Generation Immunotherapies Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Next Generation Immunotherapies Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Expansion Of Combination Immunotherapy Regimens

4.2.2 Growth In Personalized Cancer Vaccines

4.2.3 Rising Adoption Of Bispecific Antibodies

4.2.4 Increasing Focus On Reducing Immune-Related Adverse Events

4.2.5 Accelerated Clinical Trial Activity In Solid Tumors

5. Next Generation Immunotherapies Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Oncology Clinics

5.3 Research And Academic Institutes

5.4 Pharmaceutical And Biotechnology Companies

5.5 Contract Research Organizations (Cros)

6. Next Generation Immunotherapies Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Next Generation Immunotherapies Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Next Generation Immunotherapies PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Next Generation Immunotherapies Market Size, Comparisons And Growth Rate Analysis

7.3. Global Next Generation Immunotherapies Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Next Generation Immunotherapies Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Next Generation Immunotherapies Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Next Generation Immunotherapies Market Segmentation

9.1. Global Next Generation Immunotherapies Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Monoclonal Antibodies, Antibody-Drug Conjugates (ADCs), Angiotensin-Converting Enzyme (ACE) Inhibitors, Immune Checkpoint Inhibitors

9.2. Global Next Generation Immunotherapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Intravenous, Parenteral, Intratumoral, Subcutaneous, Oral

9.3. Global Next Generation Immunotherapies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Clinical Pharmacies, Other Distribution Channels

9.4. Global Next Generation Immunotherapies Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Anti-PD-1 Antibodies, Anti-PD-L1 Antibodies, Anti-CTLA-4 Antibodies, Anti-CD20 Antibodies

9.5. Global Next Generation Immunotherapies Market, Sub-Segmentation Of Antibody-Drug Conjugates (ADCs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

HER2-Targeted ADCs, CD30-Targeted ADCs, CD19-Targeted ADCs

9.6. Global Next Generation Immunotherapies Market, Sub-Segmentation Of Angiotensin-Converting Enzyme (ACE) Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

ACE Inhibitors For Cancer Therapy, ACE Inhibitors For Other Indications

9.7. Global Next Generation Immunotherapies Market, Sub-Segmentation Of Immune Checkpoint Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

PD-1 Or PD-L1 Inhibitors, CTLA-4 Inhibitors

10. Next Generation Immunotherapies Market Regional And Country Analysis

10.1. Global Next Generation Immunotherapies Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Next Generation Immunotherapies Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Next Generation Immunotherapies Market

11.1. Asia-Pacific Next Generation Immunotherapies Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Next Generation Immunotherapies Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Next Generation Immunotherapies Market

12.1. China Next Generation Immunotherapies Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Next Generation Immunotherapies Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Next Generation Immunotherapies Market

13.1. India Next Generation Immunotherapies Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Next Generation Immunotherapies Market

14.1. Japan Next Generation Immunotherapies Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Next Generation Immunotherapies Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Next Generation Immunotherapies Market

15.1. Australia Next Generation Immunotherapies Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Next Generation Immunotherapies Market

16.1. Indonesia Next Generation Immunotherapies Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Next Generation Immunotherapies Market

17.1. South Korea Next Generation Immunotherapies Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Next Generation Immunotherapies Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Next Generation Immunotherapies Market

18.1. Taiwan Next Generation Immunotherapies Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Next Generation Immunotherapies Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Next Generation Immunotherapies Market

19.1. South East Asia Next Generation Immunotherapies Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Next Generation Immunotherapies Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Next Generation Immunotherapies Market

20.1. Western Europe Next Generation Immunotherapies Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Next Generation Immunotherapies Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Next Generation Immunotherapies Market

21.1. UK Next Generation Immunotherapies Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Next Generation Immunotherapies Market

22.1. Germany Next Generation Immunotherapies Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Next Generation Immunotherapies Market

23.1. France Next Generation Immunotherapies Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Next Generation Immunotherapies Market

24.1. Italy Next Generation Immunotherapies Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Next Generation Immunotherapies Market

25.1. Spain Next Generation Immunotherapies Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Next Generation Immunotherapies Market

26.1. Eastern Europe Next Generation Immunotherapies Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Next Generation Immunotherapies Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Next Generation Immunotherapies Market

27.1. Russia Next Generation Immunotherapies Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Next Generation Immunotherapies Market

28.1. North America Next Generation Immunotherapies Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Next Generation Immunotherapies Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Next Generation Immunotherapies Market

29.1. USA Next Generation Immunotherapies Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Next Generation Immunotherapies Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Next Generation Immunotherapies Market

30.1. Canada Next Generation Immunotherapies Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Next Generation Immunotherapies Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Next Generation Immunotherapies Market

31.1. South America Next Generation Immunotherapies Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Next Generation Immunotherapies Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Next Generation Immunotherapies Market

32.1. Brazil Next Generation Immunotherapies Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Next Generation Immunotherapies Market

33.1. Middle East Next Generation Immunotherapies Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Next Generation Immunotherapies Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Next Generation Immunotherapies Market

34.1. Africa Next Generation Immunotherapies Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Next Generation Immunotherapies Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Next Generation Immunotherapies Market Regulatory and Investment Landscape

36. Next Generation Immunotherapies Market Competitive Landscape And Company Profiles

36.1. Next Generation Immunotherapies Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Next Generation Immunotherapies Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Next Generation Immunotherapies Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

37. Next Generation Immunotherapies Market Other Major And Innovative Companies

Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc (GSK), Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Boehringer Ingelheim International GmbH, Regeneron Pharmaceuticals Inc., Incyte Corporation, BioNTech SE, Xencor Inc., Fate Therapeutics Inc., Immatics N.V., Atara Biotherapeutics Inc.

38. Global Next Generation Immunotherapies Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Next Generation Immunotherapies Market

40. Next Generation Immunotherapies Market High Potential Countries, Segments and Strategies

40.1 Next Generation Immunotherapies Market In 2030 - Countries Offering Most New Opportunities

40.2 Next Generation Immunotherapies Market In 2030 - Segments Offering Most New Opportunities

40.3 Next Generation Immunotherapies Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Next Generation Immunotherapies Market, Overview Of Key Products - Product Examples
  • Table 2: Global Next Generation Immunotherapies Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Next Generation Immunotherapies Market, Supply Chain Analysis
  • Table 4: Global Next Generation Immunotherapies Market, Major Raw Material Providers
  • Table 5: Global Next Generation Immunotherapies Market, Major Resource Providers
  • Table 6: Global Next Generation Immunotherapies Market, Major Manufacturers (Suppliers)
  • Table 7: Global Next Generation Immunotherapies Market, Major Distributors And Channel Partners
  • Table 8: Global Next Generation Immunotherapies Market, Key Technologies & Future Trends
  • Table 9: Global Next Generation Immunotherapies Market, Major Trends
  • Table 10: Global Next Generation Immunotherapies Market, Major End Users
  • Table 11: Global Next Generation Immunotherapies Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Next Generation Immunotherapies Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Next Generation Immunotherapies Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Next Generation Immunotherapies Market - TAM, US$ Billion, 2025
  • Table 15: Global Next Generation Immunotherapies Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Next Generation Immunotherapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Next Generation Immunotherapies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Next Generation Immunotherapies Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Next Generation Immunotherapies Market, Sub-Segmentation Of Antibody-Drug Conjugates (ADCs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Next Generation Immunotherapies Market, Sub-Segmentation Of Angiotensin-Converting Enzyme (ACE) Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Next Generation Immunotherapies Market, Sub-Segmentation Of Immune Checkpoint Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Next Generation Immunotherapies Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Next Generation Immunotherapies Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Next Generation Immunotherapies Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Next Generation Immunotherapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Next Generation Immunotherapies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Next Generation Immunotherapies Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Next Generation Immunotherapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Next Generation Immunotherapies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Next Generation Immunotherapies Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Next Generation Immunotherapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Next Generation Immunotherapies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Next Generation Immunotherapies Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Next Generation Immunotherapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Next Generation Immunotherapies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Next Generation Immunotherapies Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Next Generation Immunotherapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Next Generation Immunotherapies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Next Generation Immunotherapies Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Next Generation Immunotherapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Next Generation Immunotherapies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Next Generation Immunotherapies Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Next Generation Immunotherapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Next Generation Immunotherapies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Next Generation Immunotherapies Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Next Generation Immunotherapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Next Generation Immunotherapies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Next Generation Immunotherapies Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Next Generation Immunotherapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Next Generation Immunotherapies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Next Generation Immunotherapies Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Next Generation Immunotherapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Next Generation Immunotherapies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Next Generation Immunotherapies Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Next Generation Immunotherapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Next Generation Immunotherapies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Next Generation Immunotherapies Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Next Generation Immunotherapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Next Generation Immunotherapies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Next Generation Immunotherapies Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Next Generation Immunotherapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Next Generation Immunotherapies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Next Generation Immunotherapies Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Next Generation Immunotherapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Next Generation Immunotherapies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Next Generation Immunotherapies Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Next Generation Immunotherapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Next Generation Immunotherapies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Next Generation Immunotherapies Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Next Generation Immunotherapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Next Generation Immunotherapies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Next Generation Immunotherapies Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Next Generation Immunotherapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Next Generation Immunotherapies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Next Generation Immunotherapies Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Next Generation Immunotherapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Next Generation Immunotherapies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Next Generation Immunotherapies Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Next Generation Immunotherapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Next Generation Immunotherapies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Next Generation Immunotherapies Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Next Generation Immunotherapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Next Generation Immunotherapies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Next Generation Immunotherapies Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Next Generation Immunotherapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Next Generation Immunotherapies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Next Generation Immunotherapies Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Next Generation Immunotherapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Next Generation Immunotherapies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Next Generation Immunotherapies Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Next Generation Immunotherapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Next Generation Immunotherapies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Next Generation Immunotherapies Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Next Generation Immunotherapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Next Generation Immunotherapies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Global Next Generation Immunotherapies Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 97: Global Next Generation Immunotherapies Market - Company Scoring Matrix
  • Table 98: Pfizer Inc. Financial Performance
  • Table 99: F. Hoffmann-La Roche Ltd. Financial Performance
  • Table 100: Merck & Co. Inc. Financial Performance
  • Table 101: AbbVie Inc. Financial Performance
  • Table 102: Sanofi S.A. Financial Performance
  • Table 103: Global Next Generation Immunotherapies Market, Competitive Benchmarking (In USD Billions)
  • Table 104: Global Next Generation Immunotherapies Market, Competitive Dashboard
  • Table 105: Global Next Generation Immunotherapies Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 106: Global, Next Generation Immunotherapies Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030
  • Table 107: Global, Next Generation Immunotherapies Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030
  • Table 108: Global, Next Generation Immunotherapies Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

List Of Figures

    Figure 1: Global Next Generation Immunotherapies Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Next Generation Immunotherapies Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Next Generation Immunotherapies Market, Supply Chain Analysis
  • Figure 4: Global Next Generation Immunotherapies Market, Major Raw Material Providers
  • Figure 5: Global Next Generation Immunotherapies Market, Major Resource Providers
  • Figure 6: Global Next Generation Immunotherapies Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Next Generation Immunotherapies Market, Major Distributors And Channel Partners
  • Figure 8: Global Next Generation Immunotherapies Market, Key Technologies & Future Trends
  • Figure 9: Global Next Generation Immunotherapies Market, Major Trends
  • Figure 10: Global Next Generation Immunotherapies Market, Major End Users
  • Figure 11: Global Next Generation Immunotherapies Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Next Generation Immunotherapies Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Next Generation Immunotherapies Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Next Generation Immunotherapies Market - TAM, US$ Billion, 2025
  • Figure 15: Global Next Generation Immunotherapies Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Next Generation Immunotherapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Next Generation Immunotherapies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Next Generation Immunotherapies Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Next Generation Immunotherapies Market, Sub-Segmentation Of Antibody-Drug Conjugates (ADCs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Next Generation Immunotherapies Market, Sub-Segmentation Of Angiotensin-Converting Enzyme (ACE) Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Next Generation Immunotherapies Market, Sub-Segmentation Of Immune Checkpoint Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Next Generation Immunotherapies Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Next Generation Immunotherapies Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Next Generation Immunotherapies Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Next Generation Immunotherapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Next Generation Immunotherapies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Next Generation Immunotherapies Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Next Generation Immunotherapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Next Generation Immunotherapies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Next Generation Immunotherapies Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Next Generation Immunotherapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Next Generation Immunotherapies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Next Generation Immunotherapies Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Next Generation Immunotherapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Next Generation Immunotherapies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Next Generation Immunotherapies Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Next Generation Immunotherapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Next Generation Immunotherapies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Next Generation Immunotherapies Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Next Generation Immunotherapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Next Generation Immunotherapies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Next Generation Immunotherapies Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Next Generation Immunotherapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Next Generation Immunotherapies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Next Generation Immunotherapies Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Next Generation Immunotherapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Next Generation Immunotherapies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Next Generation Immunotherapies Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Next Generation Immunotherapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Next Generation Immunotherapies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Next Generation Immunotherapies Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Next Generation Immunotherapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Next Generation Immunotherapies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Next Generation Immunotherapies Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Next Generation Immunotherapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Next Generation Immunotherapies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Next Generation Immunotherapies Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Next Generation Immunotherapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Next Generation Immunotherapies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Next Generation Immunotherapies Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Next Generation Immunotherapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Next Generation Immunotherapies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Next Generation Immunotherapies Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Next Generation Immunotherapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Next Generation Immunotherapies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Next Generation Immunotherapies Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Next Generation Immunotherapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Next Generation Immunotherapies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Next Generation Immunotherapies Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Next Generation Immunotherapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Next Generation Immunotherapies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Next Generation Immunotherapies Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Next Generation Immunotherapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Next Generation Immunotherapies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Next Generation Immunotherapies Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Next Generation Immunotherapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Next Generation Immunotherapies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Next Generation Immunotherapies Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Next Generation Immunotherapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Next Generation Immunotherapies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Next Generation Immunotherapies Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Next Generation Immunotherapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Next Generation Immunotherapies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Next Generation Immunotherapies Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Next Generation Immunotherapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Next Generation Immunotherapies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Next Generation Immunotherapies Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Next Generation Immunotherapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Next Generation Immunotherapies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Next Generation Immunotherapies Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Next Generation Immunotherapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Next Generation Immunotherapies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Next Generation Immunotherapies Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Next Generation Immunotherapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Next Generation Immunotherapies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Global Next Generation Immunotherapies Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 97: Global Next Generation Immunotherapies Market - Company Scoring Matrix
  • Figure 98: Pfizer Inc. Financial Performance
  • Figure 99: F. Hoffmann-La Roche Ltd. Financial Performance
  • Figure 100: Merck & Co. Inc. Financial Performance
  • Figure 101: AbbVie Inc. Financial Performance
  • Figure 102: Sanofi S.A. Financial Performance
  • Figure 103: Global Next Generation Immunotherapies Market, Competitive Benchmarking (In USD Billions)
  • Figure 104: Global Next Generation Immunotherapies Market, Competitive Dashboard
  • Figure 105: Global Next Generation Immunotherapies Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 106: Global, Next Generation Immunotherapies Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030
  • Figure 107: Global, Next Generation Immunotherapies Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030
  • Figure 108: Global, Next Generation Immunotherapies Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Read More About Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Read More About CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

Read More About Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Read More About Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Next-Generation Antibody Therapeutics Market Report 2026 - Global Outlook – By Types Of Antibodies (Monoclonal Antibodies, Polyclonal Antibodies, Bispecific Antibodies, Antibody-Drug Conjugates, Other Types), By Therapeu...

Cellular Immunotherapy Market Report 2026 - Global Outlook – By Therapy (Tumor-Infiltrating Lymphocyte (TIL) Therapy, Engineered T Cell Receptor (TCR) Therapy, Chimeric Antigen Receptor (CAR) T Cell Therapy, Natural Kill...

Therapeutic BCG Vaccines Market Report 2026 - Global Outlook – By Type (Therapy BCG, Other Types), By Demographics (Pediatrics, Adults), By End Use (Hospitals, Clinics, Other End Users) – Market Size, Trends, Strategies,...

Natural Immune Booster Market Report 2026 - Global Outlook – By Product Type (Herbal Supplements, Vitamins And Minerals, Probiotics, Functional Foods And Beverages, Essential Oils, Other Product Types), By Distribution C...

Cancer Immunotherapy Market Report 2026 - Global Outlook – By Product (Monoclonal Antibodies, Checkpoint Inhibitors, Immunomodulators, Vaccines, Cell Therapy), By Application (Lung Cancer, Breast Cancer, Colorectal Cance...

Immunoassay Market Report 2026 - Global Outlook – By Product (Reagents And Kits, Analyzers Or Instruments, Software And Services), By Specimen (Blood, Saliva, Urine, Other Specimens), By Application (Therapeutic Drug Mon...

Ruminant Vaccines Market Report 2026 - Global Outlook – By Vaccine Type (Inactivated Vaccines, Attenuated Or Modified Live Vaccines, Other Vaccine Types), By Indication (Bovine Respiratory Diseases (BRD), Diarrhea Or Sco...

Immune Health Supplements Market Report 2026 - Global Outlook – By Ingredients Type (Vitamins, Minerals, Herbal Botanical Extracts, Probiotics, Amino Acids, Omega 3 - Fatty Acids), By Form (Soft Gels Or Capsules, Tablets...

Frequently Asked Questions

The Next Generation Immunotherapies market was valued at $150.12 billion in 2025, increased to $168.33 billion in 2026, and is projected to reach $262.82 billion by 2030.

The global Next Generation Immunotherapies market is expected to grow at a CAGR of 11.8% from 2026 to 2035 to reach $262.82 billion by 2035.

Some Key Players in the Next Generation Immunotherapies market Include, Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc (GSK), Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Boehringer Ingelheim International GmbH, Regeneron Pharmaceuticals Inc., Incyte Corporation, BioNTech SE, Xencor Inc., Fate Therapeutics Inc., Immatics N.V., Atara Biotherapeutics Inc., Menarini Group, Alpine Immune Sciences Inc., Mereo Biopharma Group plc, Immunomic Therapeutics Inc., Indaptus Therapeutics Inc. .

Major trend in this market includes: Innovative CAR T-Cell Therapy Revolutionizes Cancer Treatment In India. For further insights on this market. request a sample here

North America was the largest region in the next-generation immunotherapies market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the next generation immunotherapies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us